Vital Signs - 8 May 2006

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on May 8, 2006, provides a strategic overview of the possible impact of the Massachusetts Health Plan on the uninsured population within the state as well as speculation on the potential national impact a similar plan could have within other states. Additionally, a company profile is provided on Liponex, a biopharmaceutical company that specializes in lipid therapeutics and the drug delivery properties associated with them. Reimbursement and regulatory news from the FDA and CMS are also provided for the week of April 24 - 28, 2006.

Table of Contents

Vital Signs - 8 May 2006Will the Massachusetts Health Insurance Reform Serve as a Panacea for the Growing Problem of the Uninsured?Will the Massachusetts Health Insurance Reform Serve as a Panacea for the Growing Problem of the Uninsured?




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 30-Oct-17

Region : North America

Release Date : 25-Oct-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.